Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Serena Patricia Koenig, M.D.

Concepts (201)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Serena Koenig's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Serena Koenig has written about over time.
Communicable Disease Control, 3 publications between 2001 and 2017, average publication date March 2010. Antiretroviral Therapy, Highly Active, 10 publications between 2001 and 2018, average publication date January 2013. Peritonitis, Tuberculous, 1 publications between 2013 and 2013, average publication date February 2013. Acquired Immunodeficiency Syndrome, 5 publications between 2008 and 2020, average publication date February 2014. Anti-HIV Agents, 15 publications between 2001 and 2023, average publication date February 2014. Anti-Retroviral Agents, 10 publications between 2003 and 2020, average publication date May 2014. Haiti, 38 publications between 2001 and 2023, average publication date October 2014. Tuberculosis, Pulmonary, 4 publications between 2012 and 2018, average publication date February 2015. HIV Infections, 37 publications between 2001 and 2023, average publication date May 2015. CD4 Lymphocyte Count, 9 publications between 2011 and 2019, average publication date June 2015. Earthquakes, 3 publications between 2014 and 2017, average publication date October 2015. Tuberculosis, 13 publications between 2001 and 2023, average publication date January 2016. Mass Screening, 5 publications between 2015 and 2019, average publication date April 2017. Antitubercular Agents, 6 publications between 2013 and 2022, average publication date November 2017. Tuberculosis, Multidrug-Resistant, 4 publications between 2014 and 2019, average publication date December 2017. Fluoroquinolones, 2 publications between 2018 and 2019, average publication date November 2018. Ethambutol, 1 publications between 2019 and 2019, average publication date February 2019. Ethionamide, 1 publications between 2019 and 2019, average publication date February 2019. Pyrazinamide, 1 publications between 2019 and 2019, average publication date February 2019. Isoniazid, 3 publications between 2019 and 2022, average publication date April 2020.

To see the data from this visualization as text, click here.
Koenig's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (201)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.